Help us improve the Gazette by taking this short survey —

Gazette Website Experience Survey

Notice Type
Secondary Legislation
Notice Title

Consent to the Distribution of New Medicines

Publication Date
21 May 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl2700
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Meropenem-AFT
Active Ingredient: Meropenem trihydrate 570mg equivalent to Meropenem 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturers: Qilu Antibiotics Pharmaceutical Co Limited, Jinan, China
Shenzhen Haibin Pharmaceutical Co Limited, Shenzhen City, China
   
Product: Meropenem-AFT
Active Ingredient: Meropenem trihydrate 1140mg equivalent to Meropenem 1000mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturers: Qilu Antibiotics Pharmaceutical Co Limited, Jinan, China
Shenzhen Haibin Pharmaceutical Co Limited, Shenzhen City, China


Dated this 18th day of May 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).